BSD  Home Page
Search:

4/18/2008
BSD Medical begins trading on the NASDAQ Stock Exchange April 22 under the symbol NASDAQ:BSDM

 

Hyperthermia Cancer Treatment and Therapy Systems

BSD Medical Corporation (NASDAQ: BSDM) develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy as provided by focused radio frequency and microwave energy. BSD Medical is also making major progress in the application of its technology for other therapies.


Dr. Sennewald Medizintechnik GmbH. is BSD Medical's European Distributor. Click here to go to the Dr. Sennewald Medizintechnik GmbH website.



05/02/2008: BSD Medical to Present Its Cancer Therapy Systems at the 2008 World Congress of Brachytherapy
04/29/2008: BSD Medical Announces Significant Advances in Treatment Technology at ICHO Congress in Munich
04/24/2008: Multiple Studies Demonstrate the Use of Hyperthermia Therapy in Treating Pancreatic Cancer
04/21/2008: BSD Medical to Open Trading on NASDAQ April 22
04/15/2008: BSD Medical Submits 510(k) Premarket Notification for MicroThermX®-100 Microwave Ablation System
04/10/2008: BSD Medical Corporation to Be Listed on the NASDAQ Stock Exchange
04/09/2008: BSD Medical Cites Highlights from Its Second Quarter 2008 Report * Second Quarter Sales Up by 123%
04/02/2008: ASTRO’s Official Journal Publishes 12-Year Survival Data Following Landmark Study of Cancer Treatment with Hyperthermia Therapy
03/18/2008: Review of Data from Eight U.S. Cancer Institutions Supports Use of Hyperthermia with Radiation for Treating Recurrent Breast Cancer
03/05/2008: 2008 ACRO Practice Management Guide Introduces Two Chapters on Hyperthermia Therapy
More Press Releases

If you know someone who would benefit from knowing about BSD Medical and its products please click here to send them an email directing them to this site.
Email Us
Terms of Use | Privacy Policy

Copyright © 2005 BSD Medical Corporation. All rights reserved.